No Routine CXR After Bronchoscopy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2007 by Shaare Zedek Medical Center.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Shaare Zedek Medical Center
ClinicalTrials.gov Identifier:
NCT00544479
First received: October 15, 2007
Last updated: July 20, 2011
Last verified: September 2007
  Purpose

Most pulmonologist request a routine chest-x-ray after bronchoscopy with transbronchial biopasie to exclude pneumothorax. We published a study in CHEST showing that routine chest-ray might not be necessary. We would like to conduct a propsective study to validate the results of the CHEST-study. Before and after the procedure follwing information will be collected: Age, Sex, Indication for procedure, number of biopsies and segment of biopsie, Saturation, Physical examination, Symptoms suggestive of pneumothorax. If there is no aggravation of the symptoms and/or physical examination after the procedure, as compared to before, routine chest-x-ray will NOT be done. A phone will be made 24 to 48 hours following the procedure to the patient.


Condition
Pneumothorax

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Is Routine Chest-X-Ray Necessary After Bronchoscpy With Thransbronchial Biopsie? A Prospective Study

Resource links provided by NLM:


Further study details as provided by Shaare Zedek Medical Center:

Estimated Enrollment: 350
Study Start Date: November 2007
Estimated Study Completion Date: December 2013
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

All consecutive patients with bronchoscopy and transbronchial biopsies will be enrolled in this study.

Criteria

Inclusion Criteria:

  • All patients with bronchoscopy and transbronchial biopsie

Exclusion Criteria:

  • No informed consent given
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00544479

Contacts
Contact: Gabriel Izbicki, M.D. 02-6666278 izbicki@szmc.org.il

Locations
Israel
Institue of Pulmonology, Shaare Zedek M.C. Recruiting
Jerusalem, Israel, 3235
Contact: Gabriel Izbicki, M.D.    02-6666278    izbicki@szmc.org.il   
Sponsors and Collaborators
Shaare Zedek Medical Center
Investigators
Principal Investigator: Gabriel Izbicki, M.D. Shaare Zedel Medical Center
  More Information

Publications:
Responsible Party: Dr. Gabriel Izbicki, Pulmonary Institute, Shaare Zedek Medical Center
ClinicalTrials.gov Identifier: NCT00544479     History of Changes
Other Study ID Numbers: 180964CTIL
Study First Received: October 15, 2007
Last Updated: July 20, 2011
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Pneumothorax
Pleural Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on October 29, 2014